In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evolva Holding SA

www.evolva.com

Latest From Evolva Holding SA

Deals Shaping The Medical Industry, January 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014.

BioPharmaceutical Medical Device

Santaris Acquisition By Roche May Help VCs Back New Biotechs In Europe

Roche paying $450 million for Danish biotech Santaris is likely to fuel excitement around RNA-targeting technologies and may generate a liquidity boost for Europe’s VC sector.

BioPharmaceutical Europe

Deals Shaping The Medical Industry, April 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February through March 2014.

BioPharmaceutical Medical Device

Chiesi Buys Denmark’s Zymenex For Phase III Enzyme Replacement Therapy

The purchase of Zymenex by Italy’s Chiesi has allowed VC firm Sunstone Capital to reap a second return on its investment in the Danish developer of enzyme replacement therapies.

BioPharmaceutical Denmark
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Renal System
  • Alias(es)
  • Evolva Biotech SA
  • Evolva Ltd.
  • Evolva AS
  • Evolva Biotech
  • Evolva AG
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Evolva Holding SA
  • Senior Management
  • Neil Goldsmith, CEO
    Jakob Dynnes Hansen, CFO
    Pascal Longchamp, PhD, CBO
    Jørgen Hansen, PhD, CSO
    Luc Gruner, PhD, Chief Sales & Mktg. Officer
  • Contact Info
  • Evolva Holding SA
    Phone: (41) 61 485 2000
    Duggingerstrasse 23
    Reinach, CH-4153
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register